Sarcoidosis – Diagnostics – Overview of Information and Clinical Research

Diagnosing sarcoidosis can be complex because the disease often mimics other conditions and may cause symptoms that vary widely from person to person. Understanding when to seek medical evaluation and what diagnostic tests may be used can help patients navigate this challenging process. Early and accurate diagnosis is essential to prevent potential organ damage and determine the most appropriate treatment approach.

Introduction: Who Should Undergo Diagnostics and When to Seek Them

Sarcoidosis is a condition that can affect anyone, though it appears more commonly in certain groups of people. Many individuals with this disease may not experience any symptoms at all, and the condition is sometimes discovered only when a chest X-ray is performed for an entirely different reason.^[1] This makes it challenging to know when diagnostic testing is necessary.

You should consider seeking medical evaluation if you develop persistent symptoms such as a chronic cough that does not go away, ongoing shortness of breath that interferes with daily activities, or unexplained tiredness that lasts for weeks. Other warning signs include tender red bumps on your shins, eye redness or pain, swollen lymph nodes in your neck or other areas, or a persistent low-grade fever without an obvious cause.^[2] These symptoms may suggest that something in your body needs further investigation.

Certain groups of people are at higher risk of developing sarcoidosis and may benefit from closer attention to potential symptoms. The disease is more common in individuals of African descent and those of Scandinavian background. Women develop sarcoidosis slightly more often than men, and most cases are diagnosed in people between the ages of 25 and 40, though it can occur at any age.^[3] If you have a close biological relative such as a parent, sibling, or child who has been diagnosed with sarcoidosis, your own risk is increased, and you should be especially alert to symptoms.^[2]

There are specific situations where diagnostic evaluation becomes particularly important. If you work in environments where you are exposed to insecticides, mold, dust, or certain industrial substances, and you begin experiencing respiratory symptoms or skin changes, you should discuss these concerns with your healthcare provider. Similarly, if you are taking certain medications such as some types of treatments for HIV or specific monoclonal antibodies (laboratory-made proteins that mimic the immune system’s ability to fight harmful substances), you may have an elevated risk and should seek evaluation if symptoms develop.^[4]

⚠️ Important

Many people with sarcoidosis have no symptoms at all, and the disease is often discovered incidentally during medical imaging performed for unrelated reasons. Even without symptoms, once diagnosed, regular monitoring is essential because the disease can affect vital organs without causing noticeable problems early on. Never skip follow-up appointments, even if you feel perfectly well.

Classic Diagnostic Methods Used to Identify Sarcoidosis

Diagnosing sarcoidosis is not straightforward because there is no single test that can definitively confirm the disease. Instead, doctors must combine information from your medical history, physical examination, and multiple diagnostic tests to reach a conclusion. This process can take time and requires ruling out other conditions that cause similar symptoms.^[4]

The diagnostic journey typically begins with a thorough conversation between you and your healthcare provider. Your doctor will ask detailed questions about your symptoms, including when they started, how they have changed over time, and what makes them better or worse. They will also inquire about your lifestyle, your work environment, any family history of sarcoidosis or similar diseases, and any other health conditions you may have. This conversation provides important clues about whether sarcoidosis might be the cause of your symptoms.^[4]

The physical examination follows this discussion. Your doctor will check your temperature, examine your skin for any rashes or unusual bumps, and feel your neck, armpits, and other areas for swollen lymph nodes. They will listen carefully to your chest with a stethoscope as you breathe in and out, listening for abnormal sounds that might indicate lung involvement. If you have joint pain, the doctor may examine your joints for swelling or tenderness.^[4]

Imaging tests play a central role in diagnosing sarcoidosis because the lungs are affected in about 9 out of 10 people with the condition.^[7] A chest X-ray is usually one of the first tests ordered. This simple imaging test can reveal enlarged lymph nodes in the chest or unusual patterns in the lungs that suggest sarcoidosis. In many cases, sarcoidosis is first suspected when a chest X-ray done for another purpose shows these characteristic changes.

When more detailed information is needed, doctors may order a computed tomography scan, or CT scan, of the chest. This test uses X-rays taken from multiple angles and combines them with computer processing to create detailed three-dimensional images of your lungs and surrounding structures. A CT scan can show granulomas (small clusters of inflammatory cells) that may be too small to see on a regular chest X-ray, and it helps doctors assess the extent of lung involvement more precisely.^[8]

Blood tests are another important component of the diagnostic process, though they cannot diagnose sarcoidosis by themselves. Your doctor will likely order tests to check your overall health, including a complete blood count to examine your blood cells, tests to measure how well your kidneys and liver are functioning, and tests to check your calcium levels. Sarcoidosis can cause calcium levels in the blood to become abnormally high, which can lead to other health problems if not detected and managed.^[4]^[8]

Lung function tests, also called pulmonary function tests, measure how well your lungs are working. During these tests, you will breathe into a machine that measures how much air you can breathe in and out, how quickly you can exhale, and how efficiently your lungs transfer oxygen into your bloodstream. These measurements help doctors understand whether sarcoidosis has affected your lung function and provide a baseline for monitoring changes over time.^[8]

If your symptoms suggest that sarcoidosis might be affecting your eyes, you should undergo a comprehensive eye examination. Eye involvement in sarcoidosis can cause serious problems including vision loss if not treated promptly. An eye specialist will examine the structures inside your eye and check for inflammation that could indicate the disease is affecting your vision.^[8]

When sarcoidosis affects the heart, specialized cardiac tests become necessary. An electrocardiogram, or ECG, records the electrical activity of your heart and can detect abnormal heart rhythms. An echocardiogram, which uses sound waves to create moving pictures of your heart, allows doctors to see how well your heart is pumping and whether there are any structural abnormalities. In some situations, more advanced imaging such as cardiac magnetic resonance imaging (MRI) or a positron emission tomography (PET) scan may be recommended to look for signs of cardiac sarcoidosis, which affects about 5% of all sarcoidosis patients but can be life-threatening if not recognized.^[11]

The most definitive test for confirming sarcoidosis is a biopsy, which involves removing a small sample of tissue from an affected organ and examining it under a microscope. The hallmark finding in sarcoidosis is the presence of noncaseating granulomas, which are specific types of inflammatory clusters that do not contain the central area of dead tissue typically seen in infections like tuberculosis. Biopsies can be taken from various sites depending on which organs appear to be affected, including the skin, lymph nodes, or lungs.^[8]^[5]

For lung biopsies, doctors may use a procedure called bronchoscopy, in which a thin, flexible tube with a camera is passed down your throat and into your lungs. Through this tube, small tissue samples can be collected for examination. In some cases, biopsies of lymph nodes in the chest may be obtained through a procedure called mediastinoscopy, where a small incision is made in the neck or chest to access these structures.^[8]

It is important to understand that the biopsy serves two purposes. First, it confirms the presence of the characteristic granulomas of sarcoidosis. Second, and equally important, special staining techniques are applied to the tissue sample to rule out infections caused by bacteria, fungi, or other organisms that can create similar-looking granulomas. This step is crucial because treating sarcoidosis when an infection is actually present could be dangerous.^[5]

⚠️ Important

Because sarcoidosis can look very similar to other conditions on imaging tests and even under the microscope, diagnosing it is a process of exclusion. Your doctor must rule out infections, cancers, and other inflammatory diseases before confirming sarcoidosis. This is why the diagnostic process may seem lengthy and involve multiple tests. Being patient and completing all recommended tests is essential for an accurate diagnosis.

Staging of pulmonary sarcoidosis is sometimes described using the Siltzbach classification system, which is based on the appearance of the lungs and lymph nodes on chest X-rays. Stage 0 means no visible lung abnormalities. Stage 1 shows enlarged lymph nodes in the chest but clear lungs. Stage 2 reveals both enlarged lymph nodes and lung abnormalities. Stage 3 shows lung abnormalities without enlarged lymph nodes. Stage 4 indicates permanent lung scarring or fibrosis (thickening and scarring of tissue). However, these stages do not necessarily indicate how severe the disease is or predict its course. Patients do not always progress through these stages in order, and some may see granulomas disappear completely. Only stage 4, with permanent lung damage, is irreversible.^[2]^[10]

Diagnostics for Clinical Trial Qualification

When patients with sarcoidosis are being considered for participation in clinical trials, additional diagnostic tests and evaluation criteria come into play. Clinical trials are research studies that test new treatments or approaches to managing the disease, and they have specific requirements to ensure patient safety and the validity of research results.

To qualify for enrollment in a sarcoidosis clinical trial, patients typically must first have a confirmed diagnosis based on the standard diagnostic methods described earlier. This usually means having a biopsy that demonstrates noncaseating granulomas and excludes other causes. Trials may require that this biopsy was performed within a certain timeframe, such as within the past year or two, to ensure that the diagnosis is current and accurate.

The severity and extent of disease involvement are important factors in clinical trial eligibility. Researchers often use standardized measures to assess how much sarcoidosis has affected different organs. For pulmonary sarcoidosis trials, this typically includes detailed pulmonary function testing that measures specific values such as forced vital capacity (the maximum amount of air you can forcefully exhale after taking the deepest breath possible) and diffusing capacity (how efficiently oxygen moves from your lungs into your bloodstream). Trials may specify minimum or maximum values for these measurements to ensure they are studying patients with a particular level of lung involvement.

Imaging requirements for clinical trial participation are usually more stringent than for routine diagnosis. Baseline imaging studies, such as high-resolution CT scans of the chest, may be required before enrollment to document the extent of disease. These baseline scans establish a starting point against which changes during the trial can be measured. Some trials may also require cardiac imaging such as cardiac MRI or PET scans to rule out significant heart involvement, which could affect safety or confound study results.^[11]

Blood tests for clinical trials often go beyond routine diagnostic panels. Researchers may measure specific markers of inflammation or immune activity, such as levels of certain cytokines (proteins that regulate immune responses) or measurements of angiotensin-converting enzyme (ACE), which is often elevated in people with sarcoidosis. These values help characterize the patient’s disease and may be monitored throughout the trial to assess response to treatment.

Quality-of-life assessments are increasingly recognized as important outcomes in sarcoidosis clinical trials. Patients may be asked to complete standardized questionnaires about their symptoms, fatigue levels, breathing difficulties, and how the disease affects their daily activities. These tools provide quantifiable measures of how sarcoidosis impacts patients’ lives beyond what laboratory tests and imaging can show.

Organ-specific evaluations may be required depending on the focus of the clinical trial. For trials studying treatments for sarcoidosis affecting the nervous system, neurological testing including MRI of the brain or spinal cord may be necessary. For studies focusing on cardiac sarcoidosis, extensive cardiac workup including ambulatory heart rhythm monitoring, stress testing, or specialized imaging would be expected. Trials examining skin manifestations would require detailed dermatological assessment and possibly skin biopsies.

Exclusion criteria in clinical trials often rely on diagnostic test results. For example, patients with certain abnormal blood test results indicating severe kidney or liver problems might be excluded to ensure safety. Those with evidence of active infections, discovered through diagnostic testing, would typically be ineligible because infections could interfere with the study treatment or outcomes.

Regular monitoring during clinical trials requires repeated diagnostic testing at specified intervals. This might include scheduled pulmonary function tests every few months, periodic chest imaging, routine blood work to check for side effects of experimental treatments, and eye examinations to monitor for medication-related complications. These tests serve both to assess whether the treatment is working and to ensure patient safety throughout the study period.

Prognosis and Survival Rate

Prognosis

The outlook for people with sarcoidosis varies considerably depending on multiple factors. For many individuals, the condition follows a relatively mild course. Approximately 30% of people experience spontaneous resolution, meaning the disease goes away on its own without any treatment, often within a few months to years after initial diagnosis.^[11] Another substantial portion of patients may develop symptoms suddenly but find that these improve without treatment or with minimal intervention within a similar timeframe. This is sometimes called acute sarcoidosis.

However, some people experience a more challenging course. Chronic sarcoidosis develops when the disease persists or comes back repeatedly for many years after diagnosis. This form may also be described as severe, advanced, refractory, or progressive sarcoidosis. Patients with chronic disease often require long-term treatment to control symptoms and prevent organ damage.^[15] The likelihood of developing chronic disease is influenced by several factors including the organs affected, the extent of involvement, and individual patient characteristics such as race and genetics.

The specific organs involved significantly impact prognosis. Pulmonary sarcoidosis affecting only the lymph nodes in the chest tends to have a better outlook than disease involving extensive areas of lung tissue. Cardiac sarcoidosis is particularly serious because it accounts for up to 25% of sarcoidosis-related deaths through complications such as heart rhythm abnormalities, heart failure, or sudden cardiac death.^[11] Nervous system involvement can also lead to severe complications including permanent neurological deficits if not recognized and treated promptly.

Certain patient populations appear to have different disease courses. African Americans and individuals of African descent tend to experience more severe and persistent disease compared to white populations. The stage of pulmonary disease at diagnosis, as determined by chest imaging, provides some prognostic information. For instance, stage 4 sarcoidosis with permanent lung fibrosis is irreversible and carries a worse prognosis, while earlier stages may resolve or remain stable for long periods.^[2]^[10]

The presence of certain symptoms or findings at diagnosis can influence prognosis. Lofgren’s syndrome, a specific set of symptoms including swollen lymph nodes, a particular type of skin rash called erythema nodosum, joint pain, and sometimes fever or eye symptoms, usually indicates a form of acute sarcoidosis that typically resolves completely within two years.^[4] In contrast, certain skin manifestations like lupus pernio, which causes raised, reddish-purple sores across the nose or cheeks, are associated with more chronic, persistent disease.

Most people with sarcoidosis can expect to maintain a good quality of life with appropriate monitoring and treatment when needed. However, the unpredictability of the disease means that prognosis must be individualized. Regular follow-up care is essential because sarcoidosis can flare up after periods of remission, and new organ involvement can occur even after apparent resolution. The longer someone remains symptom-free after disease activity subsides, the lower the likelihood of future flares, with most occurring within six months of stopping treatment.^[15]

Survival rate

The vast majority of people diagnosed with sarcoidosis have a normal or near-normal life expectancy. For most patients, sarcoidosis is not a life-threatening condition, and they will not die from the disease. This is particularly true for those with mild disease that resolves spontaneously or responds well to treatment.

While precise survival statistics for sarcoidosis as a whole are not extensively detailed in the available sources, it is known that serious complications leading to death occur in a minority of cases. The most concerning form is cardiac sarcoidosis, which is responsible for a disproportionate number of sarcoidosis-related deaths—accounting for up to 25% of mortality in affected individuals.^[11] However, cardiac involvement occurs in only about 5% of diagnosed sarcoidosis cases in the United States, though imaging and autopsy studies suggest that clinically silent cardiac involvement may be present in up to 25% of people with the disease.

End-stage pulmonary fibrosis, which represents irreversible scarring of lung tissue, is another potential cause of serious complications. When sarcoidosis leads to severe, progressive lung scarring, patients may develop respiratory failure or pulmonary hypertension (high blood pressure in the blood vessels of the lungs), which can significantly impact survival. In some cases of advanced lung disease, lung transplantation may be considered as a life-saving option.

It is important to emphasize that with appropriate medical monitoring and treatment when indicated, most people with sarcoidosis can prevent progression to life-threatening complications. Regular check-ups allow healthcare providers to detect worsening disease or new organ involvement early, when interventions are most likely to be effective. Even among those who require long-term treatment, many are able to control their disease and maintain good functional status and quality of life.

#1 Clinical Trials Search in Europe